Total Voting Rights

RNS Number : 9309P

Futura Medical PLC

31 May 2018

 

31 May 2018

     Futura Medical plc

      ("Futura" or "the Company")                

      Total Voting Rights

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology announces that, for the purposes of the FCA's Disclosure and Transparency Rules, the Company's total issued share capital at the date of this announcement is 121,006,002 Ordinary Shares.

Since the Company currently holds no shares in treasury, the total number of voting rights in the Company is 121,006,002 and this figure may therefore be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

For further information please contact:                           For media enquiries please contact:

Futura Medical plc                                                            Buchanan Communications Limited
Angela Hildreth, FD/COO                                                   Mark Court / Stephanie Watson / + 44 (0) 1483 685 670                                                        Sophie Wills [e-mail]                                     + 44 (0) 20 7466 5000 www.futuramedical.com
Nominated Adviser N+1 Singer Aubrey Powell / Liz Yong [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

TVRMMGFKNMLGRZM